Tower Research Capital »

Revelation Biosciences shares owned by Tower Research Capital

Quarter-by-quarter ownership of Revelation Biosciences (REVB) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Revelation Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Revelation Biosciences held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revelation Biosciences by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $758 534 1.42

More positions owned by Tower Research Capital

Spdr S&p 500 Etf Tr Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Apple (AAPL)
Amazon (AMZN)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Meta Platforms Cl A (META)
Broadcom (AVGO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Direxion Shs Etf Tr Dly Scond 3xbu (SOXL)
Alphabet Cap Stk Cl A (GOOGL)
J P Morgan Exchange Traded F Ultra Shrt Etf (JPST)
Vanguard Instl Index 0-3 Mo Treas Bil (VBIL)
Ishares Tr Rus 1000 Etf (IWB)
Ishares Tr 0-3 Mnth Treasry (SGOV)

View all positions for Tower Research Capital

Top funds holding Revelation Biosciences

Sabby Management
Armistice Capital
DRW Holdings
Jane Street
Tower Research Capital
SBI Securities
UBS Group
Danske Bank A/s

View all funds holding Revelation Biosciences